The Israeli company recalled some vials of the drug in July 2009, and the FDA recently sent the company a warning letter about violations found at its Irvine, Calif., plant, according to the report.
APP Pharmaceuticals and Hospira are both manufacturing and distributing propofol. The FDA allowed APP to import a similar European product earlier this year after the American Society of Anesthesiologists raised concerns over the shortage.
Read the Wall Street Journal’s report on the propofol shortage.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
